Oxidative stress and metabolism at rest and during exercise in persons with Down syndrome

European Journal of Preventive Cardiology

Volumn 15, Issue 1, 2008, Pages 35-42

  Flore, Patrice ^a,b   Bricout, Véronique A ^a,b   Van Biesen, Debbie ^a,d   Guinot, Michel ^b   Laporte, François ^b   Pépin, Jean Louis ^b,c   Eberhard, Yves ^a   Favre Juvin, Anne ^b   Wuyam, Bernard ^a,b   Van de Vliet, Peter ^d   Faure, Patrice ^b,c  

^a UNIV GRENOBLE ALPES   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

^c INSERM   (France)

^d UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Down syndrome; fat oxidation; insulin sensitivity; metabolic syndrome; muscular exercise; oxidative stress

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; EXERCISE; FITNESS; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPID OXIDATION; MALE; METABOLIC SYNDROME X; OXIDATIVE STRESS; POLYSOMNOGRAPHY; PRIORITY JOURNAL; REST;

ADULT; ANALYSIS OF VARIANCE; BLOOD PRESSURE DETERMINATION; CASE-CONTROL STUDIES; DOWN SYNDROME; EXERCISE; EXERCISE TEST; HUMANS; INSULIN RESISTANCE; MALE; OXIDATIVE STRESS; POLYSOMNOGRAPHY; REST;

EID: 39349112538     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/HJR.0b013e3282f2bff3     Document Type: Article

References (52)

1. Jansson U, Johansson C. Down syndrome and celiac disease. J Pediatr Gastroenterol Nutr 1995; 21: 443–445.
2. Draheim CC, Williams DP, McCubbin JA. Physical activity, dietary intake, and the insulin resistance syndrome in nondiabetic adults with mental retardation. Am J Ment Retard 2002; 107: 361–375.
3. Perez-Martin A, Dumortier M, Raynaud E, Brun JF, Fedou C, Bringer J, et al. Balance of substrate oxidation during submaximal exercise in lean and obese people. Diabetes Metab 2001; 27: 466–474.
4. Venables MC, Achten J, Jeukendrup AE. Determinants of fat oxidation during exercise in healthy men and women: a cross-sectional study. J Appl Physiol 2005; 98: 160–167.
5. Brattstrom L, Englund E, Brun A. Does Down syndrome support homocysteine theory of arteriosclerosis? Lancet 1987; 1: 391–392.
6. Eberhard Y, Eterradossi J, Therminarias A. Biochemical changes and catecholamine responses in Down's syndrome adolescents in relation to incremental maximal exercise. J Ment Defic Res 1991; 35: 140–146.
7. Flore P, Laporte F, Eberhard Y. Plasma lipid profiles of teenagers with Down syndrome after activity/diet intervention. Acta Kinesiolog 2005; 10: 61–77.
8. Hestnes A, Stovner LJ, Husoy O, Folling I, Fougner KJ, Sjaastad O. Hormonal and biochemical disturbances in Down's syndrome. J Ment Defic Res 1991; 35: 179–193.
9. De Haan JB, Wolvetang EJ, Cristiano F, Iannello R, Bladier C, Kelner MJ, et al. Reactive oxygen species and their contribution to pathology in Down syndrome. Adv Pharmacol 1997; 38: 379–402.
10. Jovanovic SV, Clements D, MacLeod K. Biomarkers of oxidative stress are significantly elevated in Down syndrome. Free Radic Biol Med 1998; 25: 1044–1048.
11. Pallardo FV, Degan P, d'Ischia M, Kelly FJ, Zatterale A, Calzone R, et al. Multiple evidence for an early age pro-oxidant state in Down syndrome patients. Biogerontology 2006; 7: 211–220.
12. Marcus CL, Keens TG, Bautista DB, von Pechmann WS, Ward SL. Obstructive sleep apnea in children with Down syndrome. Pediatrics 1991; 88: 132–139.
13. Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 2002; 165: 934–939.
14. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813–820.
15. Saengsirisuwan V, Kinnick TR, Schmit MB, Henriksen EJ. Interactions of exercise training and lipoic acid on skeletal muscle glucose transport in obese Zucker rats. J Appl Physiol 2001; 91: 145–153.
16. Magliano D, McNeil J, Branley P, Shiel L, Demos L, Wolfe R, et al. The Melbourne Atherosclerosis Vitamin E Trial (MAVET): a study of high dose vitamin E in smokers. Eur J Cardiovasc Prev Rehabil 2006; 13: 341–347.
17. Johnson P. Antioxidant enzyme expression in health and disease: effects of exercise and hypertension. Comp Biochem Physiol C Toxicol Pharmacol 2002; 133: 493–505.
18. Fenster CP, Weinsier RL, Darley-Usmar VM, Patel RP. Obesity, aerobic exercise, and vascular disease: the role of oxidant stress. Obes Res 2002; 10: 964–968.
19. Durnin JVGA, Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Med 1974; 32: 77–97.
20. Peronnet F, Massicote D. Table of non-protein respiratory quotient; an update. Can J Sport Sci 1991; 16: 23–29.
21. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502.
22. Wallace TM, Levy JC, Matthews DR. An increase in insulin sensitivity and basal beta-cell function in diabetic subjects treated with pioglitazone in a placebo-controlled randomized study. Diabet Med 2004; 21: 568–576.
23. Faure P, Lafond JL. Measurement of plasma sulfhydryl and carbonyl groups as a possible indicator of protein oxidation. In: Favier A, Cadet J, Kalyanaraman B, Fontecave M, Pierre Birkauser JL, editors. Analysis of free radicals in biological systems. Birkauser and Basel: Boston, Berlin; 1995. pp. 237–249.
24. Joint National Committee. The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1988; 148: 1023–1038.
25. The Report of an American Academy of Sleep Medicine Task Force. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 1999; 22: 667–689.
26. Wasserman K. Principles of exercise testing and interpretation. Philadelphia: Lea and Febiger Editions; 1987.
27. Despres JP, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996; 334: 952–957.
28. NCEP-ATPIII. National Institutes of Health: Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Washington, DC: US Govt. Printing Office; 2001 (NIH publ. no. 01–3670).
29. James PT, Rigby N, Leach R; International Obesity Task Force. The obesity epidemic, metabolic syndrome and future prevention strategies. Eur J Cardiovasc Prev Rehabil 2004; 11: 3–8.
30. Joshi UM, Kodavanti PR, Mehendale HM. Glutathione metabolism and utilization of external thiols by cigarette smoke-challenged, isolated rat and rabbit lungs. Toxicol Appl Pharmacol 1988; 96: 324–335.
31. Finaud J, Lac G, Filaire E. Oxidative stress. Relationship with exercise and training. Sports Med 2006; 36: 327–358.
32. Babu NP, Bobby Z, Selvaraj N, Harish BN. Increased fructosamine in non-diabetic rheumatoid arthritis patients: role of lipid peroxides and glutathione. Clin Chem Lab Med 2006; 44: 848–852.
33. Gulesserian T, Seidl R, Hardmeier R, Cairns N, Lubec G. Superoxide dismutase SOD1, encoded on chromosome 21, but not SOD2 is overexpressed in brains of patients with Down syndrome. J Investig Med 2001; 49: 41–46.
34. Muchova J, Sustrova M, Garaiova I, Liptakova A, Blazicek P, Kvasnicka P, et al. Influence of age on activities of antioxidant enzymes and lipid peroxidation products in erythrocytes and neutrophils of Down syndrome patients. Free Radic Biol Med 2001; 31: 499–508.
35. Sinet PM. Metabolism of oxygen derivatives in Down's syndrome. Ann N Y Acad Sci 1982; 396: 83–94.
36. Salem G, Rican S, Kurzinger M-L. Geography of a french crisis (folder obesity, the outbreak) [in French]. The Research 2000; 330: 31–36.
37. Ordonez FJ, Rosety M, Rosety-Rodriguez M. Influence of 12-week exercise training on fat mass percentage in adolescents with Down syndrome. Med Sci Monit 2006; 12: CR416–CR419.
38. Shimokata H, Tobin JD, Muller DC, Elahi D, Coon PJ, Andres R. Studies in the distribution of body fat: I. Effects of age, sex, and obesity. J Gerontol 1989; 44: M66–M73.
39. Fernhall B, Pitetti KH, Rimmer JH, McCubbin JA, Rintala P, Millar AL, et al. Cardiorespiratory capacity of individuals with mental retardation including Down syndrome. Med Sci Sports Exerc 1996; 28: 366–371.
40. Beange H, McElduff A, Baker W. Medical disorders of adults with mental retardation: a population study. Am J Ment Retard 1995; 99: 595–604.
41. Schnohr P, Scharling H, Jensen JS. Intensity versus duration of walking, impact on mortality: the Copenhagen City Heart Study. Eur J Cardiovasc Prev Rehabil 2007; 14: 72–78.
42. Eberhard Y, Eterradossi J, Rapacchi B. Physical aptitudes to exertion in children with Down's syndrome. J Ment Defic Res 1989; 33: 167–174.
43. Durstine JL, Grandjean PW, Davis PG, Ferguson MA, Alderson NL, DuBose KD. Blood lipid and lipoprotein adaptations to exercise: a quantitative analysis. Sports Med 2001; 31: 1033–1062.
44. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393–403.
45. Mayer-Davis EJ, D'agostino R Jr, Karter AJ, Haffner SM, Rewers MJ, Saad M, et al. Intensity and amount of physical activity in relation to insulin sensitivity: the Insulin Resistance Atherosclerosis Study. JAMA 1998; 279: 669–674.
46. American College Sport Medicine's Position Stand. Exercise and type 2 diabetes. Med Sci Sports Exerc 2000; 32: 1345–1360.
47. Tremblay A, Despres JP, Leblanc C, Craig CL, Ferris B, Stephens T, et al. Effect of intensity of physical activity on body fatness and fat distribution. Am J Clin Nutr 1990; 51: 153–157.
48. Gross M, Steffes M, Jacobs DR Jr, Yu X, Lewis L, Lewis CE, et al. Plasma F2-isoprostanes and coronary artery calcification: the CARDIA Study. Clin Chem 2005; 51: 125–131.
49. Francisco Javier O, Manuel R, Manuel RR. Regular physical activity increases glutathione peroxidase activity in adolescents with Down syndrome. Clin J Sport Med 2006; 16: 355–356.
50. Donnelly LF, Shott SR, LaRose CR, Chini BA, Amin RS. Causes of persistent obstructive sleep apnea despite previous tonsillectomy and adenoidectomy in children with Down syndrome as depicted on static and dynamic cine MRI. Am J Roentgenol 2004; 183: 175–181.
51. Schafer H, Pauleit D, Sudhop T, Gouni-Berthold I, Ewig S, Berthold HK. Body fat distribution, serum leptin, and cardiovascular risk factors in men with obstructive sleep apnea. Chest 2002; 122: 829–839.
52. Leung RS, Bradley TD. Sleep apnea and cardiovascular disease. Am J Respir Crit Care Med 2001; 164: 2147–2165.